CD4 and COVID-19: Given the divergent role of CD4+ T cells in regulating both humoral immunity and cellular immunity, we suspect that the relatively mild disease severity of these COVID-19 patients included in our study may benefit from a stronger CD4+ T cell response to SARS-CoV-2.